Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ENLV annual accounts receivable is not available.
Performance
ENLV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ENLV quarterly accounts receivable is not available.
Performance
ENLV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ENLV Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ENLV Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Enlivex Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.34 M(-28.7%) |
| Jun 2023 | - | $1.88 M(+17.5%) |
| Mar 2023 | - | $1.60 M(+9.6%) |
| Sep 2022 | - | $1.46 M(-40.4%) |
| Jun 2022 | - | $2.45 M(+107.2%) |
| Mar 2022 | - | $1.18 M(-33.4%) |
| Sep 2021 | - | $1.78 M(+32.1%) |
| Jun 2021 | - | $1.34 M(+52.0%) |
| Mar 2021 | - | $885.00 K(-28.8%) |
| Dec 2020 | $1.24 M(+36.1%) | $1.24 M(+36.1%) |
| Dec 2019 | $913.00 K | $913.00 K(+2943.3%) |
| Jun 2018 | - | $30.00 K(-83.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $178.00 K(-48.0%) |
| Jun 2017 | - | $342.00 K(-49.9%) |
| Mar 2017 | - | $682.00 K(+105.4%) |
| Sep 2016 | - | $332.00 K(-69.6%) |
| Jun 2016 | - | $1.09 M(+51.4%) |
| Mar 2016 | - | $722.00 K(-1.6%) |
| Dec 2015 | $145.00 K(+55.9%) | - |
| Sep 2015 | - | $734.00 K(+25.5%) |
| Jun 2015 | - | $585.00 K(-13.5%) |
| Mar 2015 | - | $676.00 K(+626.9%) |
| Dec 2014 | $93.00 K(+257.7%) | $93.00 K(+257.7%) |
| Dec 2013 | $26.00 K | $26.00 K |
FAQ
- What is the all time high annual accounts receivable for Enlivex Therapeutics?
- What is the all time high quarterly accounts receivable for Enlivex Therapeutics?
What is the all time high annual accounts receivable for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual accounts receivable is $1.24 M
What is the all time high quarterly accounts receivable for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly accounts receivable is $2.45 M